Lawsuit: Drugmaker improperly used charity to pay kickbacks

PHILADELPHIA — Federal prosecutors say a pharmaceutical firm improperly used a charity to pay kickbacks that subsidized Medicare patients' copayment obligations, allowing the firm to keep raising prices for the drug.

The suit filed Wednesday claims the scheme was designed to enable Mallinckrodt to raise the price of Acthar from $50 to $32,000. The drug is used to treat acute exacerbations in multiple sclerosis, lupus and rheumatoid arthritis.

Mallinckrodt could face fines of nearly $240 million. Prosecutors say the scheme operated from 2010-2014, causing the submission of millions of dollars in false Medicare claims for the drug. Drug companies are not allowed to cover patients' copayments.

Mallinckrodt said it intends to vigorously defend itself against the allegations.

Must Read

Two-day Gulf summit ends within hours amid Qatar...

Dec 5, 2017

Kuwait's emir has quickly ended a troubled summit of the Gulf Cooperation Council amid the ongoing...

$88.2B price tag for rebuilding Iraq after...

Feb 12, 2018

$88.2B price tag offered at Kuwait conference for rebuilding Iraq after Islamic State war

New US-Turkey tensions overshadow anti-IS unity...

Feb 13, 2018

A Trump administration appeal for unity among the coalition it cobbled together to destroy the...

Kuwait calms Philippines after dead worker found...

Feb 13, 2018

Kuwait's foreign minister is trying to calm the anger of the Philippines after a dead Filipina was...

East Timor, Australia open talks on maritime...

Aug 29, 2016

East Timor and Australia have begun conciliation talks in their bitter legal battle to set a...